Absidia corymbifera fungal infection in burns: A case report and review of the literature

Journal of Burn Care and Research

Volumn 29, Issue 2, 2008, Pages 416-419

  Constantinides, Joannis ^a,b   Misra, Alok ^a   Nassab, Reza ^a   Wilson, Yvonne ^a  

^a SELLY OAK HOSPITAL   (United Kingdom)

^b NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPHOTERICIN B LIPID COMPLEX; ANTIBIOTIC AGENT; CIPROFLOXACIN; MEROPENEM; NYSTATIN; PROTEINASE; VANCOMYCIN; VORICONAZOLE;

ABSIDIA; ADD ON THERAPY; ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; BURN; BURN INFECTION; BURN PATIENT; CASE REPORT; COLITIS; DEBRIDEMENT; DERMATOMYCOSIS; DRUG SUBSTITUTION; FLUID RESUSCITATION; FUNGAL VIRULENCE; FUNGUS CULTURE; HUMAN; HUMAN TISSUE; INJURY SEVERITY; MALE; MIXED INFECTION; MORBIDITY; MORTALITY; SEPSIS; SKIN ALLOGRAFT; SKIN AUTOGRAFT; SKIN BIOPSY; SKIN NECROSIS; WOUND CARE; WOUND DRESSING;

ABSIDIA; ADULT; AMPHOTERICIN B; ANTIBIOTICS, ANTIFUNGAL; BURNS; HUMANS; MALE; MUCORMYCOSIS; RISK FACTORS;

EID: 41849133203     PISSN: 1559047X     EISSN: 15590488     Source Type: Journal    
DOI: 10.1097/BCR.0b013e318166da78     Document Type: Article

References (18)

1. Becker WK, Cioffi WG, McManus AT, et al. Fungal burn wound infection: a 10-year experience. Arch Surg 1991;126:44-8.
2. Barret JP, Ramzy PI, Heggers JP, et al. Topical nystatin powder in severe burns: a new treatment for angioinvasive fungal infections refractory to other topical and systemic agents. Burns 1999;25:505-8.
3. Prabhu RM, Patel R. Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment. Clin Microbiol Infect 2004;10(Suppl 1):31-47.
4. Ribes JA, Vanover-Sams CA, Baker DJ. Zygomycetes in human disease. Clin Microbiol Rev 2000;13:236-301.
5. Cloughley R, Kelehan J, Corbett-Feeney G, et al. Soft tissue infection with Absidia corymbifera in a patient with idiopathic aplastic anemia. J Clin Microbiol 2002;40:725-7.
6. Eucker J, Sezer O, Graf B, et al. Mucormycoses. Mycoses 2001;44:253-60.
7. Hasselwandter K, Ebner MR. Microorganisms surviving for 5300 years. FEMS Microbiol Lett 1994;116:189-94.
8. Kobayashi M, Hiruma M, Matsushita A, et al. Cutaneous zygomycosis: a case report and review of Japanese reports. Mycoses 2001;44:311-15.
9. Christiaens G, Hayette MP, Jacquemin D, et al. An outbrake of Absidia corymbifera infection associated with bandage contamination in a burns unit. J Hosp Infect 2005;61:88.
10. Gordon G, Indek IM, Bross J, et al. Injury from silage wagon accident complicated by mucormycosis. J Trauma 1988;28:866-7.
11. Thami GP, Kaur S, Bawa AS, et al. Post-surgical zygmoycotic necrotizing subcutaneous infection caused by Absidia corymbifera. Clin Exp Dermatol 2003;28:251-3.
12. Garbino J, Uckay I, Amini K, et al. Absidia posttraumatic infection: successful treatment with posaconazole. J Infect 2005;51:135-8.
13. Scalise A, Barchiesi F, Viviani MA, et al. Infection due to Absidia corymbifera in a patient with a massive crush trauma of the foot. J Infect 1999;38:191-4.
14. Leong KW, Crowley B, White B, et al. Cutaneous mucormycosis due to Absidia corymbifera occurring after bone marrow transplantation. Bone Marrow Transplant 1997;19:513-15.
15. Hopwood V, Hicks DA, Thomas S, et al. Primary cutaneous zygomycosis due to Absidia corymbifera in a patient with AIDS. J Med Vet Mycol 1992;30:399-402.
16. Karam A, Ianotto JC, Metges JP, et al. Ulceration of the penis due to Absidia corymbifera. Br J Dermatol 2003;148:1286-7.
17. Williams G, Moiemen N, Frame JD. Aspergillosis presenting as Koebner's phenomenon in a healed scald. Burns 2000;26:92-6.
18. Dannaoui E, Meletiadis J, Mouton JW, et al. In vitro susceptibilities of zygomycetes to conventional and new antifungals. J Antimicrob Chemother 2003;51:45-52.